MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Repetitive Transcranial Magnetic Stimulation Therapy is a Potential Therapeutic option for Primary Orthostatic Tremor

W. Hu, J. Legacy, A. Ferng, A. Wagle Shukla (Gainesville, FL, USA)

Meeting: 2018 International Congress

Abstract Number: 1203

Keywords: Orthostatic tremor (also see Tremors)

Session Information

Date: Sunday, October 7, 2018

Session Title: Tremor

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: Determine whether low frequency repetitive transcranial magnetic stimulation (rTMS) therapy to the cerebellum improves symptoms in primary orthostatic tremor (POT)

Background: POT is a rare disabling tremor disorder characterized by high frequency tremor appearing in the legs upon standing. Treatment opportunities for POT are poor. Previous research found an increased cerebellar activity and low frequency rTMS reduces increased brain excitability.

Methods: Patients diagnosed with POT participated in a randomized double-blind placebo-controlled crossover-design study. All subjects received single session of real and sham rTMS session delivered to each cerebellar hemisphere on two separate days in random order. Nine hundred pulses were delivered consecutively to each side at a frequency of 1 Hz and at an intensity of 90% of the resting motor threshold (hand motor area). The primary outcome was the mean difference between the two arms for the Fullerton Advanced Balance Rating Scale (FABRS) standing score and the blinded video-rated standing duration measured immediately after rTMS (T1) and 60+ minutes after rTMS (T2) compared to before rTMS therapy (baseline, T0).

Results: 10 POT subjects (6 females and 4 males, mean age 70.2 ± 8.0 years, mean disease duration 13.5 ± 5.8 years) participated and tolerated the therapy well. Compared to baseline, subjects randomized to the real arm improved significantly on the FABRS standing score (baseline score 1.3; T1 score 2.3; p = 0.02) at T1 than those in the sham arm. With regards to video-rated standing duration time, there was mean increase of 126.0 ± 172.8 sec in the real arm compared to 12.9 ± 49.9 sec in the sham arm that approached significance (p = 0.11). However, at an individual level, there were 8/10 subjects in the real arm showed improvement (figure). No significant improvements were seen at T2.

Conclusions: Low frequency rTMS to cerebellum is a promising therapy for POT however requires confirmation in a larger follow-up study. A longer duration of rTMS will likely result in longer benefits.

To cite this abstract in AMA style:

W. Hu, J. Legacy, A. Ferng, A. Wagle Shukla. Repetitive Transcranial Magnetic Stimulation Therapy is a Potential Therapeutic option for Primary Orthostatic Tremor [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/repetitive-transcranial-magnetic-stimulation-therapy-is-a-potential-therapeutic-option-for-primary-orthostatic-tremor/. Accessed July 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/repetitive-transcranial-magnetic-stimulation-therapy-is-a-potential-therapeutic-option-for-primary-orthostatic-tremor/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #25676 (not found)
  • Crack Dancing: An Uncommon Drug-Induced Chorea
  • #24376 (not found)
  • #24970 (not found)
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley